- Investing Ideas
- Swedish Pharmaceuticals & Biotech Nano Cap Stocks
Swedish Pharmaceuticals & Biotech Nano Cap Stocks
Results
8
Stocks with a market cap under US$50M.
8 companies
Cantargia
Market Cap: SEK 467.4m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 1.88
7D
-0.8%
1Y
-40.6%
Sprint Bioscience
Market Cap: SEK 377.7m
A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.
SPRINT
SEK 3.58
7D
-2.2%
1Y
558.1%
Elicera Therapeutics
Market Cap: SEK 175.5m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 2.63
7D
0.4%
1Y
-53.7%
Ascelia Pharma
Market Cap: SEK 66.2m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 0.50
7D
-2.7%
1Y
-89.6%
Subgen AI
Market Cap: SEK 64.0m
Develops artificial intelligence-based models and applications to control data for government and businesses.
SUBGEN
SEK 0.063
7D
-5.7%
1Y
n/a
ODI Pharma
Market Cap: SEK 40.0m
A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.
ODI
SEK 2.18
7D
-14.2%
1Y
-5.2%
Chosa Oncology
Market Cap: SEK 34.4m
Develops oncology drugs cisplatin for the treatment of cancer.
CHOSA
SEK 0.53
7D
0%
1Y
-59.2%
Double Bond Pharmaceutical International
Market Cap: SEK 12.9m
A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.
DBP B
SEK 0.12
7D
9.1%
1Y
-72.7%